https://www.theguardian.com/society/2026/sep/04/alcohol-related-cancer-deaths
Sunday, September 6, 2026
Alcohol-related cancer deaths in US have more than doubled over three decades
Thursday, September 3, 2026
ICE holds man with stage 4 cancer in detention despite permanent US residency
https://www.theguardian.com/us-news/2026/sep/01/ice-stage-4-cancer-filipino-national
Tuesday, September 1, 2026
MAHA has arrived in Iowa — and Big Ag is reeling - POLITICO
Lahn is taking aim at fertilizers, pesticides and other farm chemicals seeping into drinking water supplies — and the agrochemical giants that make them. He believes Big Ag and Big Chemical are to blame for the state’s high cancer rates, a top issue for voters here...
https://www.politico.com/news/2026/08/31/maha-iowa-big-ag-01056179
Trump Is Unraveling a Hard-Won Rule to Reduce Toxic Pollution From Chemical Plants – Mother Jones
Friday, August 28, 2026
A drug just approved for pancreatic cancer opens a new chapter in treatment : NPR
The FDA just approved a breakthrough drug for metastatic pancreatic cancer, which is notoriously hard to treat. In clinical trials, the new pill roughly doubled how long patients survived.
Monday, August 17, 2026
Why cancer, not cost of living, may be the biggest issue in Iowa’s midterm elections
https://www.theguardian.com/us-news/2026/aug/16/iowa-midterm-elections-republicans-democrats
Wednesday, July 29, 2026
A cancer diagnosis may not be enough: Trump and Democratic states clash in court over who’s too sick to work - POLITICO
Sunday, July 26, 2026
Thursday, June 25, 2026
The EPA Relied on an Influential Glyphosate Study Even After Learning Monsanto Was a “Ghost Writer” – Mother Jones
Friday, June 12, 2026
Revlimid: The $0.25 Cancer Pill That Sold for Nearly $1,000 — ProPublica
Armstrong: And I just happened to find it. There was a lawsuit that a, um, generic drug company filed against Celgene, and buried in thousands of pages was an excerpt of a deposition of Celgene’s head of manufacturing. And a lawyer asked him flat out, “What does it cost to make this drug?” And he said 25 cents. And I remember the moment I saw that, I, I knew that it was a big markup involved, but when he said that the cost was 25 cents a pill, and it had always been 25 cents a pill, and it’s still 25 cents a pill, I was just really floored by that...
One of the former sales officials said that internally they thought they could charge whatever they wanted, that cancer patients will pay whatever price the company put on this pill. So there were, from the time Revlimid was approved by the FDA in 2005 to current day, 26 price hikes. So it was a bluff that was called. And for Celgene, it was an incredibly lucrative bet that they made...
https://www.propublica.org/podcast/revlimid-cancer-drugs-fda-healthcare
Thursday, June 11, 2026
Friday, June 5, 2026
Thursday, June 4, 2026
Strict Medicaid work rules could harm people with serious illnesses, advocates say : NPR
The nearly 400-page interim final rule released Monday makes that process even harder. For months, federal officials have been meeting with states informally and giving them guidance, and states understood that people with conditions where continuous health insurance coverage was really important would be exempt.
"What the rule says, as published, is that that's actually not enough," McIntyre explains. "The condition or the disease needs to be actively interfering with your ability to work. So people with early stage cancer who are in radiation treatment but still have the capacity to work, or people who have HIV but can still technically work, are not exempted from the work requirement."
McIntyre and others foresee situations where a person newly diagnosed with cancer, who is working, loses Medicaid because they don't fill out the paperwork correctly. That could lead to patients losing coverage when they need it most…
https://www.npr.org/2026/06/03/nx-s1-5845097/medicaid-work-requirements-cuts-hiv-cancer
Wednesday, April 22, 2026
Sunday, April 12, 2026
The Most Important Health Stories You Missed This Week (Dr. Zachary Rubin, Bench to Bedside podcast)
In Episode 9 of From Bench to Bedside, Dr. Zachary Rubin and Dr. Melanie Matheu break down the health headlines that actually matter: alternative funding programs for medications, ACIP charter changes, the worsening measles outbreak, a polio travel advisory, cuts to rabies and poxvirus testing, and a couple of good-news stories to end on hope.
Let us know what story stood out most, and share this episode with someone who wants clear, grounded takes on science, medicine, and public health.
00:00 Intro + “it’s been a week”
02:00 Alternative Funding Programs (AFPs): cheaper meds, hidden risks
05:30 Why doctors may not even know patients are using AFPs
08:30 RFK Jr. & ACIP charter changes explained
13:00 Why expertise (actually) matters in vaccine policy
16:30 Measles outbreak update (U.S. data + trends)
20:30 Why teens & adults are driving cases now
23:00 Hospitalizations + who’s at highest risk
24:30 Polio travel advisory (what to know before summer trips)
26:30 Rabies & poxvirus testing cuts: why this matters
28:00 Good news: cancer death rates declining
29:00 Good news: wedding before heart transplant
29:45 Outro
Saturday, March 7, 2026
Tackling air pollution should be part of government work to cut cancer rates, scientists say
There is increasing evidence that air pollution is associated with bladder, kidney and brain cancers and that air pollution can affect survival rates.
With home woodburning increasing, the code calls on governments to discourage and phase out solid fuels for heating, cooking and recreation. It also calls for incentives for the installation of home energy systems that do not pollute, such as heat pumps, solar power and geothermal energy...
https://www.theguardian.com/environment/2026/mar/06/tackle-air-pollution-cut-cancer-rates-scientists
Tuesday, March 3, 2026
Ivermectin takes off among cancer patients : NPR
Ivermectin is now making a comeback, after its use receded in the waning years of the pandemic. Now, especially in conservative political circles, its reputation keeps growing as a kind of cure-all for various ailments, and even for cancer — despite a lack of evidence it works.
So far, five state legislatures — in Tennessee, Arkansas, Idaho, Louisiana and Texas — have voted to make the drug available over-the-counter, causing concern among doctors who say people might overuse or misuse it, or worse — substitute ivermectin for proven treatments...
https://www.npr.org/2026/03/02/nx-s1-5729102/ivermectin-politics-treatment-cancer-evidence
Thursday, December 18, 2025
Trump selects doctor who promoted unproven covid treatment to helm U.S. cancer initiative - The Washington Post
Thursday, December 11, 2025
Synthetic chemicals in food system creating health burden of $2.2tn a year, report finds
Scientists issue urgent warning about chemicals, found to cause cancer and infertility as well as harming environment…













